Mounjaro
Mounjaro (tirzepatide) is available on the NHS in England for weight management, but access is currently limited.
At present NHS access is via a specialist weight management service to patients with a BMI of at least 40 with four or more obesity-related conditions, only after other weight management options have been tried.
The NHS plans a phased roll-out, with wider access potentially starting later in the year, most likely to patients at higher risk first. This may not be via GP practices.